InvestorsHub Logo
Followers 11
Posts 600
Boards Moderated 0
Alias Born 12/13/2016

Re: None

Friday, 04/20/2018 4:04:07 AM

Friday, April 20, 2018 4:04:07 AM

Post# of 7464
Following article leads the way. We are there!

https://www.investors.com/news/technology/gw-pharmaceuticals-epidiolex-fda-committee/

GW has led the way all along, and CNBX has followed with an even better product and biopsy options, taking longer to make a better mousetrap so to speak.

What was 3 cents a share in June 2016 will be dollars in 2018.

GLTA!!! Jim